Remed Co

Remed Co CapEx/D&A

The CapEx to Depreciation Ratio of Remed Co (302550.KQ) as of Nov 19, 2026 is 0.65. In the previous year, CapEx to Depreciation Ratio was 1.34 — a change of -51.84% (lower).

CapEx/D&A

0.65

YoY

-51.84%

Last updated:

CapEx to Depreciation Ratio of Remed Co is 2024 0.65 . CapEx to Depreciation Ratio of Remed Co was 2023 1.34 . It decreases by -51.84% lower compared to the previous year.

The Remed Co CapEx/D&A history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/D&A
Date
CapEx/D&A
Jan 1, 2017
7.93 KRW
Jan 1, 2018
67.65 KRW
Jan 1, 2019
8.17 KRW
Jan 1, 2020
2.81 KRW
Jan 1, 2021
14.35 KRW
Jan 1, 2022
9.82 KRW
Jan 1, 2023
1.34 KRW
Jan 1, 2024
0.65 KRW
The Remed Co CapEx/D&A history
YEARCapEx/D&AYoY
0.65-51.84%
1.34-86.33%
9.82-31.55%
14.35+411.01%
2.81-65.63%
8.17-87.92%
67.65+753.40%
7.93—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Remed Co Stock analysis

What does Remed Co do? REMED Co., Ltd. generates revenue through the manufacturing and sale of medical equipment, including transcranial magnetic stimulation (TMS) therapy machines, pain therapy machines, and biosignal and monitoring machines. Pain therapy machines encompass electromagnetic stimulation machines, extracorporeal shockwave therapy machines, and high intensity laser therapy machines. Biosignal and monitoring machines include patient monitors, fetal monitors, and electrocardiogram (ECG/EKG) machines. The company distributes these products domestically and internationally, targeting healthcare providers and medical facilities that require specialized therapeutic and monitoring solutions. The firm's product portfolio focuses on advanced medical devices for neurological and pain management, as well as patient monitoring. Transcranial magnetic stimulation (TMS) therapy machines are used for neurological treatments, while pain therapy machines address chronic pain conditions. Biosignal and monitoring machines support critical patient care, with electrocardiogram (ECG/EKG) machines being a key component. These products are sold to hospitals, clinics, and medical centers across domestic and overseas markets. REMED Co., Ltd. serves healthcare institutions that require specialized equipment for diagnosis, treatment, and monitoring. The domestic market includes hospitals and clinics in Daejeon, while overseas markets extend to international healthcare providers. The company’s revenue streams are derived from direct sales of its medical equipment, with no mention of additional services or licensing agreements in the business description. Remed Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remed Co stock

CapEx to Depreciation Ratio of Remed Co is 0.65 in 2024.

CapEx to Depreciation Ratio of Remed Co changed from 1.34 to 0.65, representing a -51.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Remed Co since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Remed Co with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Remed Co

All Key Metrics — Remed Co